Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AmbOx: Ambulatory Oxygen in Fibrotic Lung Disease
NCT02286063Phase 4Completed
- Sponsor
- Royal Brompton and Harefield hospitals
- Start
- Aug 2014
- Primary completion
- Jan 2018
- Modality
- Inhalation Devices
- Countries
- 1
01
Overview
A Phase 4 trial of oxygen in fibrotic interstitial lung disease (ILD), sponsored by Royal Brompton and Harefield hospitals. Started Aug 2014; status: completed.
02
Drugs
oxygen
03
Conditions
fibrotic interstitial lung disease (ILD)
Beyond the preview
Go deeper on NCT02286063.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02286063.